Salaires et Rémunération chez MySugr

MySugr was a Vienna-based HealthTech company founded in 2012 by Frank Westermann, Fredrik Debong, Madeleine Ley, and Gerald Stangl that built one of the world's most beloved and clinically effective digital diabetes management platforms — transforming the daily burden of diabetes tracking from a tedious medical obligation into an engaging, game-like experience that motivated patients to log blood glucose readings, meals, and insulin doses consistently. Its intuitive app and connected logbook gave people with Type 1 and Type 2 diabetes unprecedented clarity over their condition and measurably improved glycemic control outcomes. Acquired by Roche in 2017 for up to $100 million, MySugr became the cornerstone of Roche's open digital diabetes management platform, integrating with Roche's Accu-Chek meter ecosystem to deliver a seamless connected diabetes care experience to millions of patients globally.